ELOXX PHARMACEUTICALS INC - COM (ELOX) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2018 to Q1 2023

Type / Class
Equity / COM
Symbol
ELOX on OTC
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of ELOXX PHARMACEUTICALS INC - COM (ELOX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2023 Q1 0 $0 -$27,000 0
2022 Q4 14,626 $27,000 -$3,088,926 $1.85 1
2022 Q3 12,663,089 $2,135,083 -$59,330 $0.17 25
2022 Q2 13,000,142 $3,506,132 -$855,125 $0.27 27
2022 Q1 15,039,933 $8,417,274 -$928,950 $0.56 33
2021 Q4 16,516,778 $11,652,457 -$991,710 $0.71 37
2021 Q3 16,102,160 $26,032,201 -$1,450,114 $1.63 38
2021 Q2 16,668,137 $33,173,467 +$15,534,148 $1.99 46
2021 Q1 8,641,624 $28,688,126 -$207,922 $3.32 38
2020 Q4 8,695,626 $34,454,454 +$292,285 $3.98 41
2020 Q3 8,626,106 $22,684,084 -$240,155 $2.63 38
2020 Q2 8,703,145 $26,363,805 +$294,850 $3.03 40
2020 Q1 8,694,893 $17,041,323 -$3,545,205 $1.96 40
2019 Q4 8,633,469 $63,520,712 -$552,703 $7.36 46
2019 Q3 9,394,620 $42,434,435 -$3,360,998 $4.52 49
2019 Q2 9,708,346 $96,776,248 +$22,379,301 $9.97 48
2019 Q1 7,549,121 $88,167,850 +$687,467 $11.68 41
2018 Q4 7,484,952 $89,888,326 +$7,850,421 $12.01 39
2018 Q3 6,828,729 $116,331,249 +$23,962,345 $17.04 38
2018 Q2 5,421,392 $91,247,341 +$91,235,340 $17.07 41